Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon Z Weizer

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Asian Journal of Urology|December 22, 2017
Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy seriesZachary B Koloff, Daniel A Hamstra, John T Wei, et al.
World Journal of Urology|May 23, 2016
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomyMihai Dorin Vartolomei, Romain Mathieu, Vitaly Margulis, et al.
Medical Oncology (Northwood, London, England)|February 2, 2018
Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissectionsDaniel E Spratt, Krithika Suresh, Takahiro Osawa, et al.
Urology|May 25, 2016
Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary TractJay D Raman, Joshua I Warrick, Carla Caruso, et al.
Urology|December 3, 2014
Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinomaAditya Bagrodia, Laura-Maria Krabbe, Bishoy A Gayed, et al.
Urologic Oncology|May 11, 2010
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomyJeffery C Wheat, Alon Z Weizer, J Stuart Wolf, et al.
BJU International|March 25, 2016
Independent surgical validation of the new prostate cancer grade-grouping systemDaniel E Spratt, Adam I Cole, Ganesh S Palapattu, et al.
Cancer Research|December 17, 2015
Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted TherapyAndrew S McDaniel, Daniel H Hovelson, Andi K Cani, et al.
The Journal of Urology|December 3, 2014
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tractLaura-Maria Krabbe, Aditya Bagrodia, Ahmed Q Haddad, et al.
European Urology Focus|July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial CarcinomaStephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Asian Journal of Urology|December 22, 2017
Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy seriesZachary B Koloff, Daniel A Hamstra, John T Wei, et al.
World Journal of Urology|May 23, 2016
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomyMihai Dorin Vartolomei, Romain Mathieu, Vitaly Margulis, et al.
Medical Oncology (Northwood, London, England)|February 2, 2018
Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissectionsDaniel E Spratt, Krithika Suresh, Takahiro Osawa, et al.
Urology|May 25, 2016
Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary TractJay D Raman, Joshua I Warrick, Carla Caruso, et al.
Urology|December 3, 2014
Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinomaAditya Bagrodia, Laura-Maria Krabbe, Bishoy A Gayed, et al.
Urologic Oncology|May 11, 2010
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomyJeffery C Wheat, Alon Z Weizer, J Stuart Wolf, et al.
BJU International|March 25, 2016
Independent surgical validation of the new prostate cancer grade-grouping systemDaniel E Spratt, Adam I Cole, Ganesh S Palapattu, et al.
Cancer Research|December 17, 2015
Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted TherapyAndrew S McDaniel, Daniel H Hovelson, Andi K Cani, et al.
The Journal of Urology|December 3, 2014
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tractLaura-Maria Krabbe, Aditya Bagrodia, Ahmed Q Haddad, et al.
European Urology Focus|July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial CarcinomaStephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.
Pageof 18